YPX-C-05

CAS No. 2894823-79-9

YPX-C-05( —— )

Catalog No. M37338 CAS No. 2894823-79-9

YPX-C-05 is an isohydroxamic acid derivative and HDAC inhibitor with vasodilatory and antihypertensive activity.YPX-C-05 is used in the study of hypertension and vascular related disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    YPX-C-05
  • Note
    Research use only, not for human use.
  • Brief Description
    YPX-C-05 is an isohydroxamic acid derivative and HDAC inhibitor with vasodilatory and antihypertensive activity.YPX-C-05 is used in the study of hypertension and vascular related disorders.
  • Description
    YPX-C-05 is a hydroxamic acid-based HDAC inhibitor. YPX-C-05 exerts significant vasodilatory effects. YPX-C-05 exhibits inhibitory effects on HDACs and increases histone H4 acetylation in endothelial cells. YPX-C-05 can be used for hypertension research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2894823-79-9
  • Formula Weight
    377.39
  • Molecular Formula
    C21H19N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC=1C=CC(=CC1)C2=CC=CC(OC)=C2)NC3=CC=C(C=C3)C(=O)NO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pang PP, et al. The hydroxamic acid derivative YPX-C-05 alleviates hypertension and vascular dysfunction through the PI3K/Akt/eNOS pathway. Vascul Pharmacol. 2023 Dec 3;154:107251. ?
molnova catalog
related products
  • BRD-73954

    The first HDAC6/8 dual inhibitor with IC50s of 36/120 nM.

  • NSC 3852

    NSC 3852 is a potent inhibitor of histone deacetylase.

  • Vorinostat

    A potent HDAC inhibitor, inhibits the activities of HDAC1 and HDAC3 with IC50 of 10 nM and 20 nM, respectively.